Valuation Repligen Corporation Boerse Muenchen

Stocks

Real-time Boerse Muenchen 00:43:40 02/10/2026 +04			5-day change	1st Jan Change
158.60 ^EUR	-6.73%		+5.20%	+21.42%

09-16	Repligen Corporation Announces Retirement of Karen A. Dawes from Board of Directors, Effective September 30, 2026	CI
09-09	Repligen Corporation Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 01:30 PM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	14,643	9,401	10,039	8,064	9,224	10,002	-	-
Change	-	-35.8%	6.78%	-19.67%	14.38%	8.44%	-	-
Enterprise Value (EV) ¹	14,405	9,062	9,357	7,833	9,200	9,737	9,564	9,340
Change	-	-37.09%	3.26%	-16.29%	17.46%	5.84%	-1.78%	-2.34%
P/E	118x	52.3x	243x	-313x	191x	234x	103x	73x
PBR	8.67x	4.92x	5.09x	4.09x	4.38x	4.58x	4.27x	3.87x
PEG	-	1.2x	-3.1x	2x	-1x	-19.3x	1x	1.8x
Capitalization / Revenue	21.8x	11.7x	15.7x	12.7x	12.5x	12.1x	10.2x	8.68x
EV / Revenue	21.5x	11.3x	14.6x	12.3x	12.5x	11.8x	9.8x	8.1x
EV / EBITDA	62.5x	36.7x	73.1x	66.8x	65.6x	57x	42.9x	32.2x
EV / EBIT	66.9x	39x	99.2x	95.4x	90.4x	74.5x	53.9x	38.3x
EV / FCF	277x	104x	120x	52.3x	98x	80.7x	64x	46.9x
FCF Yield	0.36%	0.96%	0.83%	1.91%	1.02%	1.24%	1.56%	2.13%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	2.24	3.24	0.74	-0.46	0.86	0.756	1.728	2.429
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	670.5	801.5	638.8	634.4	738.3	827	976.1	1,152
EBITDA ¹	230.5	246.9	128	117.3	140.3	170.8	222.7	290.4
EBIT ¹	215.2	232.2	94.29	82.08	101.8	130.7	177.4	243.6
Net income ¹	128.3	186	41.58	-25.51	48.89	41.92	98.84	141.2
Net Debt ¹	-237.8	-339.1	-681.9	-231.8	-23.81	-264.9	-438	-662
Reference price ²	264.84	169.31	179.80	143.94	163.86	177.23	177.23	177.23
Nbr of stocks (in thousands)	55,289	55,524	55,832	56,027	56,291	56,436	-	-
Announcement Date	17/02/22	22/02/23	21/02/24	20/02/25	24/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES	28x	3.88x	15.01x	2.6%	167B
MEDTRONIC PLC	18.25x	3.37x	12.03x	3.26%	111B
STRYKER CORPORATION	21.42x	4.21x	14.72x	1.31%	105B
ESSILORLUXOTTICA	25.75x	2.52x	10.21x	2.8%	74.82B
CENCORA, INC.	16.44x	0.19x	12.1x	0.79%	59.11B
HOYA CORPORATION	28.75x	7.1x	18.34x	1.39%	51.8B
BECTON, DICKINSON AND COMPANY	34.49x	3.36x	11.49x	2.19%	48.5B
IDEXX LABORATORIES, INC.	35.36x	8.79x	24.72x	-.--%	40.79B
DEXCOM, INC.	34.67x	6.08x	19.09x	-.--%	32.54B
Average	27.02x	4.39x	15.30x	1.59%	76.68B
Weighted average by Cap.	25.47x	3.98x	14.49x	1.98%